Soodabeh Shahidsales
Overview
Explore the profile of Soodabeh Shahidsales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khalili-Tanha G, Fiuji H, Gharib M, Moghbeli M, Khalili-Tanha N, Rahmani F, et al.
Life Sci
. 2024 Oct;
358:123106.
PMID: 39419712
No abstract available.
2.
Tafti S, Azarshab A, Mahmoudian R, Khayami R, Abadi R, Ahmadi-Simab S, et al.
BMC Public Health
. 2024 Sep;
24(1):2544.
PMID: 39294628
Objective: To investigate the predictors of smoking among pregnant women in Iran, focusing on health literacy and associated socioeconomic factors. Methods: This retrospective cohort study included 103,042 pregnant women aged...
3.
Emadi Torghabeh A, Aledavood S, Soltani E, Akbari Oryani M, Akhlaghi S, Hosseini S, et al.
Front Oncol
. 2024 Sep;
14:1439730.
PMID: 39224811
Objective: Esophageal cancer is a therapeutic challenge in most healthcare systems. Most patients present with locally advanced disease at diagnosis. Concurrent chemoradiotherapy (CRT) is the standard treatment for locally advanced...
4.
Zahedi F, Jafari A, Nasiri Motlagh B, Hamedi S, Salek R, Khandoozi S, et al.
Expert Opin Drug Saf
. 2024 Jul;
:1-6.
PMID: 39076099
Background: Trastuzumab is a humanized monoclonal antibody against the human epidermal growth factor receptor 2 (HER2). This post-marketing surveillance evaluates the safety of a trastuzumab biosimilar (AryoTrust), produced by AryoGen...
5.
Vakilzadeh M, Khayami R, Daneshdoust D, Moshfeghinia R, Sharifnezhad F, Taghiabadi Z, et al.
BMC Public Health
. 2024 Apr;
24(1):1081.
PMID: 38637741
Background: The prevalence of tobacco use among various cancer types in Iran remains a significant concern, necessitating a comprehensive analysis to understand the extent and patterns of consumption. This study...
6.
Hadji M, Marzban M, Rashidian H, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al.
Acta Oncol
. 2023 Nov;
62(12):1661-1668.
PMID: 37934078
Background: Opium use has been associated with an increased risk of cancers of the lung, oesophagus, and pancreas, and it was recently classified by the International Agency for Cancer Research...
7.
Khojasteh-Leylakoohi F, Mohit R, Khalili-Tanha N, Asadnia A, Naderi H, Pourali G, et al.
Sci Rep
. 2023 Oct;
13(1):16678.
PMID: 37794108
Pancreatic ductal adenocarcinoma (PDAC) is associated with a very poor prognosis. Therefore, there has been a focus on identifying new biomarkers for its early diagnosis and the prediction of patient...
8.
Rahmani F, Hashemian P, Tabrizi A, Ghorbani Z, Ziaeemehr A, Alijannejad S, et al.
Indian J Cancer
. 2023 Oct;
60(3):295-302.
PMID: 37787188
Glioblastoma (GBM) is one of the most aggressive tumors in the brain with high mortality worldwide. Despite recent advances in therapeutic strategies, the survival rate remains low in patients with...
9.
Rezaei Z, Dastjerdi K, Allahyari A, Shahidsales S, Talebian S, Maharati A, et al.
Toxicol Appl Pharmacol
. 2023 Aug;
475:116652.
PMID: 37557922
Recently, miRNAs have been regarded as potential candidates for mediating therapeutic functions by targeting genes related to drug response. In this study, we suggested that plasma miRNAs may be correlated...
10.
Mahmoudian R, Farshchian M, Golyan F, Mahmoudian P, Alasti A, Moghimi V, et al.
Crit Rev Oncol Hematol
. 2023 Jul;
189:104068.
PMID: 37468084
Preclinical models are extensively employed in cancer research because they can be manipulated in terms of their environment, genome, molecular biology, organ systems, and physical activity to mimic human behavior...